IntelliPharmaCeutics International (TSXV:IPCI) Dividend Payout Ratio : 0.00 (As of Aug. 2023)

View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International Dividend Payout Ratio?

IntelliPharmaCeutics International's dividend payout ratio for the months ended in Aug. 2023 was 0.00.

The historical rank and industry rank for IntelliPharmaCeutics International's Dividend Payout Ratio or its related term are showing as below:

TSXV:IPCI's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-21), the Dividend Yield % of IntelliPharmaCeutics International is 0.00%.

IntelliPharmaCeutics International's Dividends per Share for the months ended in Aug. 2023 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

IntelliPharmaCeutics International Dividend Payout Ratio Historical Data

The historical data trend for IntelliPharmaCeutics International's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Dividend Payout Ratio Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Dividend Payout Ratio

Get a 7-Day Free Trial

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of IntelliPharmaCeutics International's Dividend Payout Ratio

For the Biotechnology subindustry, IntelliPharmaCeutics International's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Dividend Payout Ratio falls into.

IntelliPharmaCeutics International Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

IntelliPharmaCeutics International's Dividend Payout Ratio for the fiscal year that ended in Nov. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Nov. 2022 )	/	EPS without NRI (A: Nov. 2022 )
	=	0	/	-0.129
	=	N/A

IntelliPharmaCeutics International's Dividend Payout Ratio for the quarter that ended in Aug. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Aug. 2023 )	/	EPS without NRI (Q: Aug. 2023 )
	=	0	/	-0.079
	=	N/A

IntelliPharmaCeutics International (TSXV:IPCI) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

IntelliPharmaCeutics International Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

IPCIF:USA I4AA:Germany

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines